Clinical trial
Huperzine A in Alzheimer's Disease
NCT00083590 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00083590 |
|---|---|
| Title | Huperzine A in Alzheimer's Disease |
| Official title | A Multi-Center, Double-Blind, Placebo-Controlled Therapeutic Trial to Determine Whether Natural Huperzine A Improves Cognitive Function |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | Alzheimer's Disease Cooperative Study (ADCS) Neuro-Hitech Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Huperzine A |
| Enrollment | 150 |
| Start date | Apr 1, 2004 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | May 27, 2004 |
| Last update posted | Feb 21, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: